Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P32
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -17.59% |
| Q2 2025 | -151.38% |
| Q1 2025 | 304.45% |
| Q4 2024 | -3.52% |
| Q3 2024 | -168.64% |
| Q2 2024 | 289.79% |
| Q1 2024 | 21.78% |
| Q4 2023 | -0.43% |
| Q3 2023 | 20.85% |
| Q2 2023 | 33.56% |
| Q1 2023 | -35.70% |
| Q4 2022 | 7.46% |
| Q3 2022 | -15.49% |
| Q2 2022 | 16.89% |
| Q1 2022 | -20.23% |
| Q4 2021 | 15.81% |
| Q3 2021 | -1.26% |
| Q2 2021 | 10.17% |
| Q1 2021 | -78.76% |
| Q4 2020 | -16.11% |
| Q3 2020 | -126245.32% |
| Q2 2020 | -53.31% |
| Q1 2020 | 0.00% |